Externally-Led Patient Focused Drug Development Meeting

Your Bighearted patient experience will convey the importance and urgency of new therapies to the Food & Drug Administration (FDA), researchers, pharma, healthcare providers, and federal regulators, leveraging the unique power of your lived experience.